Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy

被引:7
|
作者
Tian, Hongwei
Yang, Chengzhi
Song, Yunhu
Wang, Hongyue
Yuan, Jiansong
Cui, Jingang
Liu, Shengwen
Hu, Fenghuan
Yang, Weixian
Jiang, Xiaowei
Qiao, Shubin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, 167 North Lishi Rd, Beijing, Peoples R China
[2] Peking Union Med Coll, 167 North Lishi Rd, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Microvascular density; Myocardial fibrosis; Hypertrophic obstructive cardiomyopathy; HEART-FAILURE; TISSUE; DYSFUNCTION; DISARRAY; COLLAGEN; YOUNG;
D O I
10.1159/000493005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a myocardial disease characterized by fibrosis and microvascular ischemia. Microvessels play a critical role in myocardial fibrosis in HOCM. However, it remains unclear whether or not myocardial fibrosis is associated with microvascular density (MVD) changes. Objective: The aim of the present study was to investigate whether a reduction in MVD is related to myocardial fibrosis in HOCM cardiac samples. Methods: We analyzed MVD and fibrosis in myectomy left ventricular (LV) septal wall specimens from 53 HOCM patients. Control myocardium from the LV septal wall was collected at autopsy of 9 individuals who died of noncardiac causes. Results: The fibrosis ratio (% area) in HOCM was higher and the MVD was lower than that in control subjects (i.e., 12.7 +/- 10.0 vs. 4.0 +/- 1.4%, p = 0.012, and 480.9 +/- 206.7 vs. 1,425 +/- 221/mm(2), p < 0.001). Patients with mild fibrosis had a higher MVD than patients with moderate fibrosis (i.e., 568.2 +/- 214.8 vs. 403.2 +/- 167.8/mm(2), p = 0.006) and patients with severe fibrosis (i.e., 568.2 +/- 214.8 vs. 378.6 +/- 154.0/mm(2), p =0.024). Furthermore, a significant negative correlation was found between myocardial fibrosis and MVD in HOCM patients (r = -0.40, p = 0.003), which was also found in mild fibrosis (r = -0.40, p = 0.043), moderate fibrosis (r = -0.50, p = 0.024), and severe fibrosis (r = -0.24, p = 0.61), although no significant differences were observed in severe fibrosis. Additionally, we demonstrated that late gadolinium enhancement was negatively correlated with MVD (r = -0.37, p = 0.03) and positively correlated with fibrosis (r = 0.44, p = 0.01). Conclusion: HOCM patients had a higher myocardial fibrosis ratio and a lower MVD. The severity of myocardial fibrosis was negatively correlated with MVD in HOCM. These findings showed that a reduced MVD may contribute to myocardial fibrosis in HOCM. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:202 / 211
页数:10
相关论文
共 50 条
  • [41] Differences in the extent of fibrosis in obstructive and nonobstructive hypertrophic cardiomyopathy
    Avegliano, Gustavo
    Politi, Maria T.
    Costabel, Juan P.
    Kuschnir, Paola
    Trivi, Marcelo
    Ronderos, Ricardo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2019, 20 (06) : 389 - 396
  • [42] Association of Coronary Microvascular Rarefaction and Myocardial Fibrosis With Coronary Artery Disease
    Campbell, Duncan J.
    Francis, Victoria C. M.
    Young, Gregory R.
    Woodford, Noel W. F.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (21):
  • [43] Impact of Sympathetic Activity and Fibrosis on Microvascular Function in Hypertrophic Cardiomyopathy
    Gaemperli, Oliver
    Gebhard, Catherine
    O'Hanlon, Rory
    Ismail, Tevfik
    Wage, Ricardo
    Clark, Susan
    Camici, Paolo G.
    Prasad, Sanjay
    Rimoldi, Ornella E.
    CIRCULATION, 2010, 122 (21)
  • [44] NONSURGICAL MYOCARDIAL REDUCTION FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - REPLY
    SIGWART, U
    LANCET, 1995, 346 (8990): : 1624 - 1624
  • [45] Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy Is It Appropriate?
    Sigwart, Ulrich
    CIRCULATION, 2019, 140 (01) : 11 - 12
  • [46] The treatment of hypertrophic obstructive cardiomyopathy by nonsurgical myocardial reduction
    Knight, C
    Gunning, M
    Henein, M
    Kilner, P
    Gibson, D
    Sigwart, U
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1996, 9 (05) : 393 - 397
  • [47] Myocardial Neprilysin Expression in Patients With Obstructive Hypertrophic Cardiomyopathy
    Armstrong, David W.
    Su, Yan Ru
    Shah, Ashish S.
    Absi, Tarek
    Gupta, Deepak K.
    Wells, Quinn
    Brinkley, D. M.
    Stevenson, Lynne W.
    Merryman, W. David
    CIRCULATION, 2022, 146
  • [48] Outcomes of Acute Myocardial Infarction in Hypertrophic Obstructive Cardiomyopathy
    Abdullah, Obai
    Enezate, Tariq
    Al-Dadah, Ashraf
    Omran, Jad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B331 - B331
  • [49] WORSE FIBROSIS AND MICROVASCULAR ISCHEMIA ARE ASOCIATED WITH HIGHER INCIDENCE OF ARRHYTHMIC EVENTS IN NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    Pozios, Iraklis
    Villalobos, Celia Corona
    Sorensen, Lars
    Luo, Hongchang
    Bravo, Paco
    Pinheiro, Aurelio
    Dimaano, Veronica
    Kamel, Ihab
    Zimmerman, Stefan
    Abraham, Maria
    Abraham, Theodore
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A850 - A850
  • [50] Prognostic impact of myocardial microvascular abnormalities in patients with hypertrophic cardiomyopathy
    Inoue, K
    Ohtsuka, T
    Ogimoto, A
    Shigematsu, Y
    Higaki, J
    CIRCULATION, 2005, 112 (17) : U510 - U510